{"id":742234,"date":"2012-03-28T08:30:00","date_gmt":"2012-03-28T08:30:00","guid":{"rendered":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-appoints-michael-j-holston-as-chief-ethics-and-compliance-officer\/"},"modified":"2023-03-22T00:04:25","modified_gmt":"2023-03-22T04:04:25","slug":"merck-appoints-michael-j-holston-as-chief-ethics-and-compliance-officer","status":"publish","type":"news_item","link":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-appoints-michael-j-holston-as-chief-ethics-and-compliance-officer\/","title":{"rendered":"Merck Appoints Michael J. Holston as Chief Ethics and Compliance Officer"},"content":{"rendered":"<p class=\"bwalignc\">       Long-time Merck and Schering-Plough Executive Richard S. Bowles to        Retire     <\/p>\n<p>WHITEHOUSE STATION, N.J.&#8211;(BUSINESS WIRE)&#8211;Merck (NYSE: MRK), known as MSD outside the United States and Canada,        today announced the appointment of Michael J. Holston as chief ethics        and compliance officer effective June 25, 2012. He will succeed Richard        S. Bowles, who has decided to retire from the company after more than 35        years with Merck and the former Schering-Plough. In his new role,        Holston, 49, will report directly to Kenneth C. Frazier, Merck\u2019s        chairman and chief executive officer, and will serve on the company\u2019s        Executive Committee. He will be responsible for driving high ethical        standards and compliance across the company&#8217;s business globally.     <\/p>\n<p>       \u201cEthical business practices and good corporate governance are important        to us and our stakeholders, and we are committed to adhering to the laws        and regulations governing our activities worldwide,&#8221; said Frazier. &#8220;We        are delighted to welcome Mike as our new chief ethics and compliance        officer. His extensive experience managing compliance with healthcare        laws across international businesses and his background with Merck and        our industry make Mike a terrific leader for our ethics and compliance        organization and a member of our Executive Committee.     <\/p>\n<p>       &#8220;I also want to thank Rick Bowles for nearly four decades of dedicated        service to Merck and Schering-Plough. His strong leadership established        the global compliance organization for the combined new company        following the merger with Schering-Plough. He developed the right        structure, capabilities and leadership for the function, creating a        solid base upon which Mike can continue to build a world class ethics        and compliance organization going forward.&#8221;     <\/p>\n<p>       Holston most recently served as executive vice president and general        counsel for Hewlett-Packard Company, where he oversaw compliance,        government affairs, privacy, ethics operations and legal affairs. Prior        to his role with Hewlett-Packard, Holston was a partner in the        litigation practice at Morgan, Lewis &amp; Bockius LLP, where he served as        external counsel to Merck on matters such as product litigation,        government investigations and compliance with healthcare laws and        regulations. Before joining Morgan Lewis, he served as a prosecutor in        the criminal division of the U.S. Attorney&#8217;s Office for the Eastern        District of Pennsylvania.     <\/p>\n<p>       \u201cI&#8217;m excited to be joining Merck at this important period of change for        the company and the pharmaceutical industry,\u201d said Holston. \u201cI look        forward to working with dedicated and talented people across the        company, helping to champion Merck&#8217;s high ethical and compliance        standards so the company can focus on what it does best \u2013 discovering        and developing innovative new medicines and vaccines.&#8221;     <\/p>\n<p>       Holston received his J.D. from Villanova University School of Law,        Villanova, Penn. and a B.S.M.E. from the University of Notre Dame, South        Bend, Indiana. He also is a fellow in the American College of Trial        Lawyers.     <\/p>\n<p>       <b>About Merck<\/b>     <\/p>\n<p>       Today&#8217;s Merck is a global healthcare leader working to help the world be        well. Merck is known as MSD outside the United States and Canada.        Through our prescription medicines, vaccines, biologic therapies, and        consumer care and animal health products, we work with customers and        operate in more than 140 countries to deliver innovative health        solutions. We also demonstrate our commitment to increasing access to        healthcare through far-reaching policies, programs and partnerships. For        more information, visit <a target=\"_blank\" href=\"http:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fvip2-msd.com\/merckcom-migrated&amp;esheet=50220543&amp;lan=en-US&amp;anchor=vip2-msd.com\/merckcom-migrated&amp;index=1&amp;md5=875b381b5d9146e9859e1494368e69c0\" rel=\"noopener\"><span class=\"bwuline\">vip2-msd.com\/merckcom-migrated<\/span><\/a><span class=\"bwuline\">        <\/span>and connect with us on Twitter, Facebook and YouTube.     <\/p>\n<p>       <b>Forward-Looking Statement<\/b>     <\/p>\n<p>       This news release includes \u201cforward-looking statements\u201d within the        meaning of the safe harbor provisions of the United States Private        Securities Litigation Reform Act of 1995. Such statements may include,        but are not limited to, statements about the benefits of the merger        between Merck and Schering-Plough, including future financial and        operating results, the combined company\u2019s plans, objectives,        expectations and intentions and other statements that are not historical        facts. Such statements are based upon the current beliefs and        expectations of Merck\u2019s management and are subject to significant risks        and uncertainties. Actual results may differ from those set forth in the        forward-looking statements.     <\/p>\n<p>       The following factors, among others, could cause actual results to        differ from those set forth in the forward-looking statements: the        possibility that all of the expected synergies from the merger of Merck        and Schering-Plough will not be realized, or will not be realized within        the expected time period; the impact of pharmaceutical industry        regulation and health care legislation in the United States and        internationally; Merck\u2019s ability to accurately predict future market        conditions; dependence on the effectiveness of Merck\u2019s patents and other        protections for innovative products; and the exposure to litigation        and\/or regulatory actions.     <\/p>\n<p>       Merck undertakes no obligation to publicly update any forward-looking        statement, whether as a result of new information, future events or        otherwise. Additional factors that could cause results to differ        materially from those described in the forward-looking statements can be        found in Merck\u2019s 2011 Annual Report on Form 10-K and the company\u2019s other        filings with the Securities and Exchange Commission (SEC) available at        the SEC\u2019s Internet site (<a target=\"_blank\" href=\"http:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sec.gov&amp;esheet=50220543&amp;lan=en-US&amp;anchor=www.sec.gov&amp;index=2&amp;md5=a0510ff4b4def88023011ac115e691bf\" rel=\"noopener\">www.sec.gov<\/a>).     <\/p>\n<\/p>\n<p><p>       Merck<br \/>Media:<br \/>Ron Rogers, 908-423-6449<br \/>or<br \/>Investors:<br \/>Carol        Ferguson, 908-423-4465     <\/p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the appointment of Michael J. Holston as chief ethics and compliance officer effective June 25, 2012. He will succeed Richard S. Bowles, who has decided to retire from the company after more than 35 years with Merck and the former Schering-Plough. In his new role, Holston, 49, will report directly to Kenneth C. Frazier, Merck\u2019s chairman and chief executive officer, and will serve on the company\u2019s Executive Committee. He will be responsible for driving high ethical standards and compliance across the company&#8217;s business globally. \u201cEthical business practices and good corporate governance are important to us and our stakeholders, and we are committed to adhering to the laws and regulations governing our activities worldwide,&#8221; said Frazier. &#8220;We are delighted to welcome Mike as our new chief ethics and compliance officer. His extensive experience managing compliance with healthcare laws across<\/p>\n","protected":false},"template":"","meta":{"_acf_changed":false,"bdl_company_name":[],"bdl_item_external_link":[],"inpsyde_pem_expiration_date":[],"inpsyde_pem_expiration_action":[],"footnotes":""},"tags":[53,289],"class_list":["post-742234","news_item","type-news_item","status-publish","hentry","tag-corporate-news","tag-press-release"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Merck Appoints Michael J. Holston as Chief Ethics and Compliance Officer - Merck.com<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-appoints-michael-j-holston-as-chief-ethics-and-compliance-officer\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Merck Appoints Michael J. Holston as Chief Ethics and Compliance Officer - Merck.com\" \/>\n<meta property=\"og:description\" content=\"Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the appointment of Michael J. Holston as chief ethics and compliance officer effective June 25, 2012. He will succeed Richard S. Bowles, who has decided to retire from the company after more than 35 years with Merck and the former Schering-Plough. In his new role, Holston, 49, will report directly to Kenneth C. Frazier, Merck\u2019s chairman and chief executive officer, and will serve on the company\u2019s Executive Committee. He will be responsible for driving high ethical standards and compliance across the company&#039;s business globally. \u201cEthical business practices and good corporate governance are important to us and our stakeholders, and we are committed to adhering to the laws and regulations governing our activities worldwide,&quot; said Frazier. &quot;We are delighted to welcome Mike as our new chief ethics and compliance officer. His extensive experience managing compliance with healthcare laws across\" \/>\n<meta property=\"og:url\" content=\"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-appoints-michael-j-holston-as-chief-ethics-and-compliance-officer\/\" \/>\n<meta property=\"og:site_name\" content=\"Merck.com\" \/>\n<meta property=\"article:modified_time\" content=\"2023-03-22T04:04:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-content\/uploads\/sites\/152\/2022\/03\/Merck.png\" \/>\n\t<meta property=\"og:image:width\" content=\"3056\" \/>\n\t<meta property=\"og:image:height\" content=\"1380\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/merck-appoints-michael-j-holston-as-chief-ethics-and-compliance-officer\\\/\",\"url\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/merck-appoints-michael-j-holston-as-chief-ethics-and-compliance-officer\\\/\",\"name\":\"Merck Appoints Michael J. Holston as Chief Ethics and Compliance Officer - Merck.com\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/#website\"},\"datePublished\":\"2012-03-28T08:30:00+00:00\",\"dateModified\":\"2023-03-22T04:04:25+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/merck-appoints-michael-j-holston-as-chief-ethics-and-compliance-officer\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/merck-appoints-michael-j-holston-as-chief-ethics-and-compliance-officer\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/merck-appoints-michael-j-holston-as-chief-ethics-and-compliance-officer\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"News\",\"item\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news-archive\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Merck Appoints Michael J. Holston as Chief Ethics and Compliance Officer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/#website\",\"url\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/\",\"name\":\"Merck.com\",\"description\":\"Just another vip-msd.com site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Merck Appoints Michael J. Holston as Chief Ethics and Compliance Officer - Merck.com","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-appoints-michael-j-holston-as-chief-ethics-and-compliance-officer\/","og_locale":"en_US","og_type":"article","og_title":"Merck Appoints Michael J. Holston as Chief Ethics and Compliance Officer - Merck.com","og_description":"Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the appointment of Michael J. Holston as chief ethics and compliance officer effective June 25, 2012. He will succeed Richard S. Bowles, who has decided to retire from the company after more than 35 years with Merck and the former Schering-Plough. In his new role, Holston, 49, will report directly to Kenneth C. Frazier, Merck\u2019s chairman and chief executive officer, and will serve on the company\u2019s Executive Committee. He will be responsible for driving high ethical standards and compliance across the company's business globally. \u201cEthical business practices and good corporate governance are important to us and our stakeholders, and we are committed to adhering to the laws and regulations governing our activities worldwide,\" said Frazier. \"We are delighted to welcome Mike as our new chief ethics and compliance officer. His extensive experience managing compliance with healthcare laws across","og_url":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-appoints-michael-j-holston-as-chief-ethics-and-compliance-officer\/","og_site_name":"Merck.com","article_modified_time":"2023-03-22T04:04:25+00:00","og_image":[{"width":3056,"height":1380,"url":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-content\/uploads\/sites\/152\/2022\/03\/Merck.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-appoints-michael-j-holston-as-chief-ethics-and-compliance-officer\/","url":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-appoints-michael-j-holston-as-chief-ethics-and-compliance-officer\/","name":"Merck Appoints Michael J. Holston as Chief Ethics and Compliance Officer - Merck.com","isPartOf":{"@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/#website"},"datePublished":"2012-03-28T08:30:00+00:00","dateModified":"2023-03-22T04:04:25+00:00","breadcrumb":{"@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-appoints-michael-j-holston-as-chief-ethics-and-compliance-officer\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-appoints-michael-j-holston-as-chief-ethics-and-compliance-officer\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-appoints-michael-j-holston-as-chief-ethics-and-compliance-officer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"News","item":"https:\/\/vip2-msd.com\/merckcom-migrated\/news-archive\/"},{"@type":"ListItem","position":2,"name":"Merck Appoints Michael J. Holston as Chief Ethics and Compliance Officer"}]},{"@type":"WebSite","@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/#website","url":"https:\/\/vip2-msd.com\/merckcom-migrated\/","name":"Merck.com","description":"Just another vip-msd.com site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/vip2-msd.com\/merckcom-migrated\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"acf":{"news_item_workflow_id":"27aac468-0cff-4c4c-b325-56cc90eb3b4c","news_item_aria_label":"","media_files":null,"document_path":"https:\/\/s2.q4cdn.com\/584635680\/files\/doc_news\/Merck-Appoints-Michael-J-Holston-as-Chief-Ethics-and-Compliance-Officer-2012.pdf","file":""},"_links":{"self":[{"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/news_item\/742234","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/news_item"}],"about":[{"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/types\/news_item"}],"version-history":[{"count":0,"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/news_item\/742234\/revisions"}],"wp:attachment":[{"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/media?parent=742234"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/tags?post=742234"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}